Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in type 2 diabetes: A pilot prospective randomized trial

Journal of Diabetes

Volumn 2, Issue 1, 2010, Pages 36-40

  Patel, Parini ^a   Poretsky, Leonid ^a   Liao, Emilia ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Insulin resistance; Type 2 diabetes; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; ADIPONECTIN; COLECALCIFEROL; GLUCOSE; HEMOGLOBIN A1C; LIPID;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADIPONECTIN; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; TRIGLYCERIDES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77953471076     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2009.00057.x     Document Type: Article

References (20)

1. Pittas A, Lau J, Hu F, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007; 92: 2017-29.
2. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005; 28: 1228-30.
3. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980; 209: 823-5.
4. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003; 88: 157-61.
5. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short term vitamin D and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001; 86: 1633-7.
6. Borissova A, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003; 57: 258-61.
7. Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia. 1997; 40: 344-7.
8. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000; 85: 2402-10.
9. Clark S, Stumpf W, Madhabananda S, DeLuca H, Tanaka Y. Target cells for 1, 25 dihydroxyvitamin D3 in the pancreas. Cell Tissue Res. 1980; 209: 515-20.
10. Bourlon P, Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1, 25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol. 1999; 160: 87-95.
11. Chiu K, Chu A, Go V, Saad M. Hypovitaminosis D is associated with insulin resistance and beta cell dysfuncftion. Am J Clin Nutr. 2004; 79: 820-5.
12. Scragg R, Sowers M, Bell C. Serum 25- hydroxyvitamin D, diabetes and ethnicity in the third national health and nutrition examination survey. Diabetes Care. 2004; 27: 2813-8.
13. Liu E, Meigs JB, Pittas AG et al. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 2009; 139: 329-34.
14. Pittas A, Dawson-Hughes B, Li T et al. Vitamin D and Calcium Intake in Relation to Type 2 Diabetes in Women. Diabetes Care. 2006; 29: 650-6.
15. Boer I, Tinker L, Connelly S et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care. 2008; 31: 701-7.
16. Knekt P, Laaksonen M, Mattila C et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008; 19: 666-71.
17. Orwoll E, Riddle M, Prince M. Effects of vitamin D on insulin and glucagon secretion in non-insulin dependent diabetes mellitus. Am J Clin Nutr. 1994; 59: 1083-7.
18. Ljunghall S, Lind L, Lithell H et al. Treatment with one-alpha- hydroxycholecalciferol in middle-aged men with impaired glucose tolerance-prospective randomized double-blind study. Acta Med Scand. 1987; 222: 361-7.
19. Vieth R. Vitamin D supplementation, 25- hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999; 69: 842-56.
20. Heaney R, Davies K, Chen T, Holick M, Barger-Lux M. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003; 77: 204-10.